A Cost Effectiveness Analysis (CEA) of Phenytoin (PHT) Versus Levetiracetam (LEV) for Early Seizure Pharmacoprophylaxis After Traumatic Brain Injury (TBI) From a US Institutional Perspective: An Upgrade of a Cost Minimization Analysis (CMA)
Value in Health - United Kingdom
doi 10.1016/j.jval.2018.04.1402
Full Text
Open PDFAbstract
Available in full text
Date
May 1, 2018
Authors
Publisher
Elsevier BV